The oncoprotein E7 from human papillomavirus-16 (HPV-16 E7) plays a pivotal role in HPV postinfective carcinogenesis, and its physical interaction with host cell targets is essential to its activity. We identified a novel cellular partner for the viral oncoprotein: the actin-binding protein gelsolin (GSN), a key regulator of actin filament assembly and disassembly. In fact, biochemical analyses, generation of a 3D molecular interaction model and the use of specific HPV-16 E7 mutants provided clear cut evidence supporting the crucial role of HPV-16 E7 in affecting GSN integrity and function in human immortalized keratinocytes. Accordingly, functional analyses clearly suggested that stable HPV-16 E7 expression induced an imbalance between polymeric and monomeric actin in favor of the former. These events also lead to changes of cell cycle (increased S phase), to the inhibition of apoptosis and to the increase of cell survival. These results provide support to the hypotheses generated from the 3D molecular interaction model and encourage the design of small molecules hindering HPV-induced host cell reprogramming by specifically targeting HPV-16 E7-expressing cells.
Introduction
A large number of infectious agents can cause or contribute to human cancer onset. Among them, the human papillomavirus (HPV), a small DNA virus that infects human epithelial tissues, plays an important role. The over 100 HPV genotypes have been subdivided into 'lowrisk' and 'high-risk' strains. High-risk HPVs have been associated not only with anogenital carcinomas (mainly cancers of the uterine cervix) (1,2) but also with other cancers, such as oropharyngeal squamous cell carcinomas (3), cutaneous malignancies (non-melanoma skin cancers) (4) and other tumors (5, 6) . Among the high-risk genotypes, HPV-16 and HPV-18 have most commonly been associated with neoplastic diseases (1) .
HPV-induced tumors are often diagnosed several years after viral infection and show the viral genome physically integrated into cancer cell chromosomes. Such a process partially disrupts the HPV genome and also preserves the E6 and E7 viral oncogenes expression, thus stabilizing the production of the related oncoproteins. The role of these factors is to favor the postinfective viral replication within normal epithelial tissues. Notwithstanding, these viral oncoproteins also act as 'multitasking' tools exerting crucial functions in the processes of cellular transformation and tumor progression (2, (7) (8) (9) . Indeed, E6 and E7 are well known for their ability to weaken normal cell cycle control mechanisms and to modulate the cellular apoptotic response. HPV transforming properties are mainly attributed to a complex network of relationships between its oncoproteins and the host cell proteome. As an example, high-risk HPV E6 and E7 are able to interact and neutralize key oncosuppressor proteins, as p53 and the Retinoblastoma family factors (10) (11) (12) .
In the attempt to delve into the molecular mechanisms elicited by the HPV oncoproteins in inducing cellular transformation, the analysis of the interactome network of the E7 oncoprotein from HPV-16 (HPV-16 E7) with the host cell proteins was undertaken. In this study, we screened a human keratinocyte library by using the yeast two-hybrid (Y2H) technology and identified the protein gelsolin (GSN) as a potential binding partner of HPV-16 E7. GSN is a ubiquitously expressed member of the superfamily of actin-binding proteins, which is capable of severing, capping and nucleating actin cytoskeletal filaments. It also plays a role as multifunctional regulator of cell structure and metabolism. In addition, it has been recently involved in signal transduction, acting as a transcriptional coactivator (13) (14) (15) (16) . GSN is a protein composed of six domains, termed G 1 to G 6 (13) and is located in intracellular (cytoplasmic isoform) and extracellular (plasmatic isoform) compartments (17) . A peculiar role of GSN is played in cellular apoptotic processes, where antithetic functions have been described, depending upon the pathophysiological context (16) , and further complicated by the fact that caspase-3 cleavage of GSN generates two products (18) with opposite functions: a N-terminal fragment (N-termGSN) with Ca 2+ -independent proapoptotic activity (19) and a C-terminal moiety (C-termGSN) that promotes cell survival (20) (21) (22) (23) . GSN has been described to have a role in several diseases (16) . As concerns cancer, either a decrease or an increase of GSN expression has been reported (16) , so that its role in tumor biology still remains undefined.
In this study, we investigated the ability of HPV-16 E7 to physically interact with the full-length cytoplasmic isoform, as well as with its N-terminal, caspase-3-generated, proapoptotic moiety. The interference of HPV-16 E7 with the cleavage of the full-length GSN and with the proapoptotic capability of the N-terminal GSN fragment is also analyzed. These results can represent the bases for the establishment of novel and specific therapeutic strategies against HPV-induced epithelial cancers.
Materials and Methods

Y2H selection
Y2H screening, performed using HPV-16 E7 as bait, was done as described (24) .
Plasmids, constructs and transfections
Cloning of full-length wild-type and mutant HPV-16 E7, GSN and N-termGSN complementary DNA sequences and fusion proteins expression are described under Supplementary Material, available at Carcinogenesis Online.
Cell lines
Wild-type HaCaT cells, HPV-16 E7-expressing HaCaT cells and the respective control cells were cultured as described (25) .
Western blot analysis
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analysis with Enhanced chemiluminescence detection were performed as described (26) . Antibodies and dilutions are described under Supplementary Material, available at Carcinogenesis Online.
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PepSets™ technology
To precisely identify the amino acids (aa) involved in the interaction between HPV-16 E7 and GSN, the PepSets™ technology (Mimotopes Pty Ltd, Clayton, Victoria, Australia) was employed as described (25) .
Docking of HPV-16 E7 to GSN
The dimer of the CR3 zinc binding domain of HPV-16 E7 in the aa range 45-95 has been built by homology modeling with the program MODELLER (9v8) (27) , using as a template the structure of HPV-45 E7 dimer [Protein Data Bank (PDB), 2F8B].
Docking of the modeled dimer of the HPV-16 E7 CR3 domain onto human GSN (PDB 3FFK, chain A) in the aa range 131-350 (numbering relative to the cytoplasmic isoform of GSN, UniProt P06396-2) has been carried out with Hex (v6.1) (28) .
In vitro binding assay HPV-16 E7 or N-termGSN in vitro translation, using 35 S-methionine as a radioactive label, was done as described (26) . Aliquots of reaction mixtures containing in vitro-translated proteins were added to glutathione-Sepharose 4B beads coupled to 4 μg of recombinant glutathione-S-transferase (GST)-GSN or GST (negative control), to demonstrate radiolabeled HPV-16 E7 coprecipitation, or with 4 μg of recombinant GST-HPV-16 E7, to demonstrate radiolabeled N-termGSN coprecipitation. Incubation, SDS-PAGE and detection were done as described (29) .
In vivo coimmunoprecipitations
Control, HPV-16 E7-expressing cells and HaCaT cells transfected with wild-type and mutant T7-tagged HPV-16 E7, were incubated in radioimmunoprecipitation assay buffer plus protease inhibitors (30) for 30 min on ice. Sonicated protein extracts were centrifuged at 14 000 g for 10 min at 4°C. Lysates (800 μg) were cleared and incubated with one of the following antibodies: monoclonal anti-Hemagglutinin (HA) epitope, anti-T7 Tag (Novagen, Darmstadt, Germany) or anti-GSN, for 2 h with rotation, followed by incubation with protein A/G-Sepharose beads in radioimmunoprecipitation assay buffer. Beads were then subjected to four rounds of washing with 1 ml of ice-cold lysis buffer and then immunoprecipitates were eluted by boiling in electrophoresis sample buffer. Proteins were resolved through SDS-PAGE, transferred to polyvinylidene difluoride membranes and probed with specific antibodies as indicated in the western blotting section.
In vitro cleavage of recombinant GSN by caspase-3
Bacterially expressed GST-GSN (1 μg) was preincubated for 30 min at 37°C in assay buffer (50 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid pH 7.4, 100 mM NaCl, 0.1% [(3-cholamidopropyl)-dimethylammonio]1-propanesulfonate, 10 mM dithiothreitol, 1 mM ethylenediaminetetraacetic acid, 10% glycerol), without protease inhibitors, containing equimolar amount of recombinant wild-type and mutant HPV-16 E7 protein or GST as negative control. Proteolytic reaction was initiated by addition of 10 U of recombinant active caspase-3 (BIOMOL International, L.P. Plymouth Meeting, PA). After incubation at 37°C for 3 h, the reaction was stopped and cleaved products were analyzed by 10% SDS-PAGE followed by Coomassie Blue staining.
DNA fragmentation analysis
This procedure is described under Supplementary Material, available at Carcinogenesis Online.
G-actin and F-actin ratio
Filamentous and globular actin (F-actin and G-actin, respectively) fractions were obtained from HPV-16 E7-expressing HaCaT cells lysates (31) . Equal amounts (10 μg) of soluble and insoluble protein fractions were resolved through 10% SDS-PAGE, transferred onto polyvinylidene difluoride membranes and probed with the antiactin monoclonal antibody.
Fluorescence microscopy This procedure is described under Supplementary Material, available at Carcinogenesis Online.
Flow cytometry analysis
Statistical analysis
Statistical analysis of the results was performed using the two-tailed Student's t-test, with GraphPad Prism v5.01 for Windows (GraphPad Software, San Diego, CA). P < 0.01 were considered statistically significant.
Results
HPV-16 E7 interacts with the actin-binding protein GSN
To explore the HPV-16 E7 interactome, a human keratinocyte complementary DNA library was screened using the Y2H technology and employing HPV-16 E7 as bait, as described (25) . Among the rescued plasmids, the complementary DNA sequence encoding for the actinbinding protein GSN (NM_198252.2, Gelsolin) was identified by direct DNA sequencing.
To substantiate the protein-protein interaction identified via Y2H between HPV-16 E7 and GSN, HPV-16 E7 was translated in vitro in the presence of 35 S-methionine and challenged with Schistosoma japonicum GST or with a GST-GSN recombinant protein. After pull-down with glutathione-Sepharose, proteins were resolved by SDS-PAGE (10% acrylamide), and the dried gel analyzed using a phosphorimager apparatus. In this setting, radiolabeled HPV-16 E7 coprecipitated in the presence of GST-GSN only ( Figure 1 , panel A). To validate this result, HaCaT immortalized human keratinocytes constitutively expressing HA-tagged HPV-16 E7 via the pLXSN retroviral vector were used; in parallel, a cell clone expressing the empty retroviral vector (control) was employed (32) . Lysates from pLXSN-HA-E7-infected (HPV-16 E7-expressing) and from pLXSN-HA-infected HaCaT cells (control) were prepared. After immunoprecipitation using an anti-HA antibody, western blot analysis detected coprecipitated GSN only in HPV-16 E7-expressing cells ( Figure 1 , panel B). Consistently, in the same lysates, after immunoprecipitation using an anti-GSN antibody, western blot analysis detected coprecipitated HA-tagged HPV-16 E7 in HPV-16 E7-expressing cells only ( Figure 1 , panel C). In both pictures in panels B and C, the lysate used as reference in the leftmost lane was from pLXSN-HA-E7-infected (HPV-16 E7-expressing) HaCaT cells.
Identification of the aa sequences mediating the interaction between HPV-16 E7 and GSN
To identify the HPV-16 E7 aa regions involved in GSN binding, the PepSets® technique was employed, as described previously (32) . A set of 12mer oligopeptides, with a 9-aa overlap, spanning across the entire length of the HPV-16 E7 protein (98 aa) was synthesized on polypropylene rods. Rod-bound oligopeptides were then assayed for their ability to physically interact with recombinant GSN, whose amount captured by each single rod was then determined immunoenzymatically (enzyme-linked immunosorbent assay). The results identified the HPV-16 E7 region comprised between aa 55 and 78 as the most crucial for GSN binding ( Figure 1 , panel D). These epitopes were encompassed within the CR3 region of the viral oncoprotein.
Effect of HPV-16 E7 on in vivo and in vitro cleavage of GSN by caspase-3
HPV-16 E7-expressing HaCaT cells display higher resistance toward UVB-induced apoptosis (32) . Being GSN involved in modulation of the apoptotic processes, mainly via its cleavage by caspase-3, the amounts of full-length GSN and of C-termGSN (representative of the amount of cleaved GSN) were determined in HPV-16 E7-expressing HaCaT cells and in the relative control cells by means of western blot. In this setting, after UVB exposure (5 mJ/cm 2 for 1 min), HPV-16 E7-expressing HaCaT cells displayed a considerable reduction of the amount of C-termGSN compared with control cells, which was paired with a slightly increased amount of full-length, uncleaved GSN ( Figure 2 , panel A). C-termGSN appeared undetectable in the same cells in the absence of UVB exposure ( Figure 2 , panel B).
To establish if the decrease in GSN cleavage in HPV-16 E7-expressing HaCaT cells could be due to a direct relationship between the presence of the HPV-16 E7 molecule and caspase-3 activity, an in vitro enzymatic assay was carried out. Purified recombinant GSN was incubated with 10 U of active caspase-3 in the presence or absence of purified recombinant HPV-16 E7. Reaction was incubated at 37° C for 180 min. The protein mixture was then resolved by SDS-PAGE (10% acrylamide) and visualized by Coomassie blue staining ( Figure 2 , panel C). Caspase-3 activity on the GSN molecule was denoted by a decrease in the amount of fulllength GSN (GST-GSN) accompanied by the parallel increase in its cleavage products (GST-N-termGSN and C-termGSN; lane 2 versus lane 1). In the same experimental setting, the presence of GST-HPV-16 E7 reduced significantly the amount of cleaved GSN with a parallel increase in full-length GSN (lane 3 versus lane 2). The same effect was not replicated by the addition of a recombinant GST molecule (lane 5 versus lane 3). These results suggest a specific inhibitory effect of HPV-16 E7 on the caspase-3 ability to cleave GSN, possibly due to a physical interference of HPV-16 E7 with the substrate recognition binding site of caspase-3 on GSN.
Docking of HPV-16 E7 to GSN
To model the interaction between HPV-16 E7 and GSN, it was considered that the viral factor showed the capacity to bind to the full-length GSN protein, thus inhibiting its cleavage by caspase-3 between GSN residues Asp352 and Gly353 (19) , within the G3 domain (13) . It was hypothesized that the viral factor could target a region inside the G2 domain because it hosts residues involved in F-actin-binding (33) and severing (34) , as well as residues with a role in the intramolecular binding of the short C-terminal α-helix (Figure 3, panel A) , the latter assigned with a calciumdepending regulatory function (35, 36) . Therefore, the possibility that HPV-16 E7 might interact with the G2 domain of GSN would have multiple effects by contemporarily targeting the binding sites of the regulatory C-terminal α-helix and of actin, possibly altering the severing function of GSN, and protecting the GSN site involved in proteolytic cleavage. Hence, a docking search to predict the possible binding mode of the dimer of the CR3 domain of HPV-16 E7 (E7 CR3 dimer) on the G2 domain of the full-length GSN (PDB, entry 3FFN) was carried out. Since a region within the G2 domain serves for the intramolecular and reversible interaction with the regulatory C-terminal α-helix ( Figure 3 , panel A), GSN residues 717-731 (containing such regulatory helix and few linking residues) were removed prior to docking. The docking of E7 CR3 on the full-length GSN is shown in Figure 3 , panel C. In this complex, the residues of the E7 CR3 dimer close to any heavy atom of the bound GSN (using a 4 Å distance threshold) were aa 45 Figure 1, panel D) . Since the physical interaction with HPV-16 E7 was detected on the N-termGSN resulting from the cleavage by caspase-3, we evaluated whether the viral factor could bind N-termGSN; likewise, it was predicted for the full-length GSN despite the G 1-3 domains, which are common to both full-length and cleaved 
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protein, exhibit major conformational rearrangements (37). Therefore, it was assessed whether the predicted binding region maintained full exposure and same conformation in the two protein forms. To this aim, the structures of the full-length GSN and the N-terminal moiety of the protein (respectively, PDB entries 3FFN and 3FFK, Figure 3 , panels A and B) were compared across their common domains G [1] [2] [3] . Two distinct large regions characterized by same conformation in both protein forms were identified in the aa ranges ca. 146-233 and 245-322 (Figure 3 , panels A and B), including, respectively, the G 2 and G 3 domains of GSN. In particular, the aa range 146-233 supported our initial hypothesis that the binding of HPV-16 E7 could involve the G2 domain. Therefore, it was proposed that HPV-16 E7 targets the same region on both the full-length GSN and the N-termGSN, as shown in Figure 3 , panels C and D.
To validate the possibility that HPV-16 E7 could interact also with the N-terminal moiety of GSN, a GSN deletion mutant lacking the C-terminal portion of the protein was generated. This mutant corresponded to the N-terminal GSN fragment, comprising aa 1-352 (N-termGSN) , produced by caspase-3 cleavage on the full-length GSN molecule. In in vitro pull-down experiments, 35 S-radiolabeled N-termGSN retained the ability to interact with GST-HPV-16 E7 (Figure 3, panel E) . In addition, after transfection of control and HPV-16 E7-expressing HaCaT cells with a plasmid for transient overexpression of green fluorescent protein-N-termGSN (GFP-N-termGSN) or GFP (control), an immunofluorescence analysis was performed. Cells double stained for tagged HPV-16 E7 (red) and nucleus (with Hoechst 33258, blue) displayed, when present, a strong nuclear colocalization (yellow) between HPV-16 E7 and GFP-N-termGSN (green; Figure 3 , panel F).
Down-modulation of the N-termGSN proapoptotic activity by HPV-16 E7
The caspase-generated N-termGSN moiety binds and severs actin filaments (F-actin) in a Ca 2+ -independent manner and competes with full-length GSN binding to actin, disrupting the actin-DNase I interaction, enhancing DNase I proapoptotic activity (38) . Based on F-actin binding site location on GSN (aa 196-227) (13), it was hypothesized that HPV 16-E7 could compete for the same binding The red and cyan colors correspond, respectively, to the GSN residues 146-233 (the first large region of the protein that maintains same structure and remains solvent-exposed in both the full-length and N-terminal fragment of GSN, chosen as best candidate for the docking of the E7 viral factor) and 245-322 (the second large conformationally stable and solvent-exposed region in both forms of GSN), the violet color indicates the regulatory C-terminal α-helix of the full-length form of GSN (residues 721-730) and the green color indicates the rest of the GSN structure. A few residues (aa 717-731) including the C-terminal α-helix were removed to allow the docking of E7 CR3 domain dimer onto the full-length GSN. Note that the full-length and the N-terminal fragment of GSN are oriented with their HPV-16 E7 binds to gelsolin and inhibits apoptosis region on N-termGSN, thus counteracting its effect on F-actin depolymerization and its proapoptotic activity. HPV-16 E7-expressing and control HaCaT cells were both engineered to overexpress N-termGSN ( Figure 4, panel A) . In this setting, the apoptotic DNA degradation pattern was determined. N-termGSN-overexpressing cells showed, as expected, DNA fragmentation, a phenomenon drastically hampered in HPV-16 E7-expressing cells (Figure 4, panel B) . Additionally, determination of G-actin and F-actin in N-termGSN-transduced cells showed an increased F-actin/G-actin ratio, based essentially on the decreased G-actin level found in HPV-16 E7-expressing cells, possibly due to F-actin 'stabilization', compared with control ( Figure 4 , panel C). Table S1 , available at Carcinogenesis Online).
HPV-16 E7 and N-termGSN interplay modulates the intracellular amount of F-actin
Mutant HPV-16 E7 molecules unable to bind GSN
On the bases of the HPV-16 E7 epitopes identified as mediators of the interaction with the GSN molecule and with the N-termGSN moiety, we engineered two deletion mutants of the oncoprotein, namely HPV-16 E7Δ62-66 and HPV-16 E7Δ71-75. These deletion ranges were chosen with the aim to remove residues crucial for the interaction with GSN, as determined by peptide mapping experiments. In particular, the 62-66 and 71-75 aa ranges appeared interesting because the former is comprised within the sequences of the second and fourth best interacting peptides (respectively, peptides 55-66 and 61-72, Figure 1, panel D) , whereas the latter is shared by the peptides scoring at the first and third highest interaction positions (respectively, peptides 67-78 and 64-75, Figure 1, panel D) .
T7-tagged HPV-16 E7, as well as the mutant HPV-16 E7Δ62-66 and HPV-16 E7Δ71-75 constructs, was thus overexpressed in wildtype HaCaT cells via transient transfection. Immunoprecipitation of the cell lysates with an anti-T7 Tag antibody followed by western blot against GSN showed coprecipitated GSN in cells transfected with wild-type HPV-16 E7 only ( Figure 5, panel A) , ascertaining that binding of GSN to both HPV-16 E7Δ62-66 and HPV-16 E7Δ71-75 was undetectable under these conditions. To assess the capability of these HPV-16 E7 mutants to protect the GSN molecule from caspase-3 cleavage, the in vitro assay described previously (see Figure 2 , Caspase-3 cleavage was monitored by the amount of the GST-GSN splicing products observable after SDS-PAGE and Coomassie blue staining (GST-NtermGSN and C-termGSN). The presence of HPV-16 E7 strongly reduced the amount of cleaved GST-GSN (lane 3), accompanied by a parallel increase of the full-length GST-GSN construct, whereas both mutants were definitely less efficient in inhibiting GSN cleavage, though HPV-16 E7Δ71-75 displayed some residual protection against caspase-3 activity. On the left side, molecular weight markers migration is reported. (C) Fluorescence microscopy. Wild-type HaCaT HPV-16 E7 binds to gelsolin and inhibits apoptosis panel C) was redone utilizing also the GST-HPV-16 E7Δ62-66 and GST-HPV-16 E7Δ71-75 mutants. As shown in Figure 5 , panel B, the mutant oncoproteins, especially HPV-16 E7Δ62-66, resulted by far less efficient in protecting GSN from caspase-3 digestion in vitro, a result consistent with their defective interaction with GSN. Now, to investigate in depth the significance of the physical interaction between N-termGSN and HPV-16 E7 in the F-actin distribution, we overexpressed wild-type HPV-16 E7, or the Δ62-66 and Δ71-75 mutants (all as pAmCyan-C1 constructs, blue), and/or GFP-N-termGSN, or GFP alone (green), in wild-type HaCaT cells. Intracellular distribution of F-actin was then morphologically evaluated by means of tetramethyl rhodamine iso-thiocyanate-phalloidin (red). Overexpression of N-termGSN alone caused cell shrinkage, whereas HPV-16 E7 overexpression induced cell spreading. The effect of N-termGSN was partially reverted by HPV-16 E7 only when the wild-type oncoprotein was coexpressed, whereas HPV-16 E7Δ62-66 and Δ71-75 mutants, with compromised ability to interact with N-termGSN, resulted essentially ineffective ( Figure 5, panel C) . These data were strongly corroborated by F-actin cytofluorimetric determination, where N-termGSN expression reduced in any case F-actin expression. In the same setting, only wild-type HPV-16 E7 enhanced F-actin expression ( Figure 5 , panel D), being both mutant oncoproteins less efficient also in counteracting the effect of N-termGSN overexpression. Consistent with the data reported in Figure 5 , panel B, concerning GSN digestion by caspase-3, the Δ71-75 mutant, rather than the Δ62-66, maintained some residual protective activity in contrasting N-term GSN ability to reduce F-actin amount. Statistical significance is reported in the figure legend. In the same setting, when cell cycle analysis was accomplished cytofluorimetrically, the results obtained were consistent with those shown in Supplementary Table S1, available at Carcinogenesis Online, where N-termGSN was overexpressed in control-and HPV-16 E7-infected cells. Not surprisingly, expression of the HPV-16 E7 mutant molecules resulted ineffective in relieving N-termGSN-induced apoptosis (Table I) .
Discussion
The data herein presented support the hypothesis of a physical association between the viral oncoprotein HPV-16 E7 and the cellular factor GSN, as well as the functional implications of this interaction. HPV-16 E7 CR3 region, which is involved in the binding to GSN, is known to interact and interfere with the activity of several factors involved in cell cycle control, carbohydrate metabolism and transcriptional regulation (39) . In addition, recent evidence supports the role of the CR3 region in cell detoxification, redox status and control of the apoptotic processes via the c-jun N-terminal kinase pathway (32) . In our study, supported also by the results obtained using two different HPV-16 E7 mutant constructs, aa sequences comprised within the HPV-16 E7 CR3 region appear specifically involved in the binding to GSN and able to influence its fate and function, at least at two different levels. Actually, binding of HPV-16 E7 to the full-length GSN molecule hindered its cleavage by caspase-3, thus downregulating the generation of the two major proteolytic fragments, N-termGSN, with proapoptotic activity, and C-termGSN, with antiapoptotic activity. To make this matter more complex, HPV-16 E7 was able to bind to the N-termGSN moiety as well, thus decreasing its proapoptotic effect. It was also possible to obtain 3D models illustrating the interaction between the HPV-16 E7 CR3 dimer and full-length GSN or N-termGSN fitting with these experimental data. In particular, it was found that both these forms of the GSN protein share the conformationally stable aa region 146-233 within the G2 domain. This GSN region might be targeted by HPV-16 E7 for several reasons. First, it maintains the same local structure regardless the strong conformational differences characterizing most of the common domains of full-length GSN and N-termGSN. Second, it is crucial for the activities of both full-length GSN and N-termGSN, being involved in the binding of F-actin (33, 40) ; hence binding of HPV-16 E7 is likely to be responsible for the interference with this interaction. In third place, this GSN region hosts the residues involved in the binding of the regulatory C-terminal α-helix that contributes to keep the fulllength GSN in an inactive state, and, according to our docking model, HPV-16 E7 might replace the function of this helix, therefore blocking the initiation of the severing activity on GSN. Moreover, through its interaction with the viral factor, it might aid the stabilization of the compact structure of the full-length GSN, thus impeding its proteolytic cleavage.
On these premises, HPV-16 E7 emerges as a crucial factor in the framework of GSN regulatory mechanisms and thus in downstream functional consequences. One of the most intriguing details is that both GSN and HPV-16 E7 play an important role in epithelial-mesenchymal transition (EMT). Indeed, GSN silencing induces EMT in the MCF-10A non-transformed human mammary epithelial cells and suggests an active involvement of GSN in controlling the equilibrium between E-and N-cadherin via a mechanism involving the Snail transcription factor (41) . On the other hand, HPV-16 E7 expression in primary human foreskin keratinocytes induces EMT, with increased vimentin and fibronectin expression and E-cadherin down-modulation at the protein level. Interestingly, these phenomena are not accompanied by parallel changes in messenger RNA expression of these cellular factors (42). The mechanism described here could thus represent one of the posttranslational, non-transcriptional events elicited by high-risk HPVs in order to induce EMT.
As it concerns actin microfilament network, we found that HPV-16 E7 can induce increased F-actin, i.e. polymeric actin, levels ( Figure 5 , panels C and D), which could be ascribed to an impaired GSN severing function due to the binding with the viral oncoprotein. The results obtained using the two HPV-16 E7 mutants strongly support this hypothesis. Thus, since it is well known that cells awakening the event of mesenchymal transition become motile and increase their migration ability, thus acquiring a metastatic phenotype (43) , it can be hypothesized that changes in F/G actin ratios instructed via GSN could specifically be impaired by HPV-16 E7. Hence, since it was suggested that other actin cytoskeleton linker proteins, such as ezrin of the ezrin-radixin-moesin protein family, could be involved in the development of HPV-induced cervical lesions (44), we can suggest that HPV could trigger a complex framework of events leading to actin cytoskeleton reorganization contributing to increase motility and metastatic spreading of cancer cells (45) .
Another key point is the effect of HPV-16 E7 on the fate of GSN, as far as it concerns its cleavage by caspase-3 between residues Asp352 and Gly353. As specified above, this cleavage produces the N-termGSN and C-termGSN moieties, with proapoptotic and antiapoptotic activities, respectively. Thus, HPV-16 E7 appears here to play a complex role, impeding caspase-3 cleavage on GSN and also inhibiting the proapoptotic effect of the N-termGSN moiety. Such a HPV-16 E7 behavior appears in full agreement with the well-known ability of HPV to reprogram the host cell to favor its replication and cells were transfected with control vectors, GFP-N-termGSN (green) or pAmCyan-C1-HPV-16 E7 (blue) or cotransfected with both vectors. In addition, GFP-NtermGSN was also cotransfected with pAmCyan-C1-HPV-16 E7Δ62-66 or pAmCyan-C1-HPV-16 E7Δ71-75. Cells were then assayed for polymerization state of actin. F-actin was detected by means of tetramethyl rhodamine iso-thiocyanate-phalloidin. (D) Semiquantitative flow cytometry analysis. Histogram showing flow cytometry analysis of actin polymerization state performed in cells stained with tetramethyl rhodamine iso-thiocyanate-phalloidin for F-actin determination. N-termGSN reduced the amount of F-actin, whereas only wild-type HPV-16 E7 contrasted efficiently this phenomenon. In ordinate median fluorescence intensity ± standard deviation obtained from three independent experiments was reported. Transfection efficiency was the same as reported in Table I ← to enhance its survival, a behavior also responsible for the rise and selection of cellular clones with a high frequency of transformation (10) (11) (12) 46) . HPV-16 E7 and HPV-16 E6 are factors able to influence an intricate array of molecular mechanisms within the host cell, mostly oriented to promote cell survival and replication. Interestingly, these oncoproteins are void of any enzymatic activity but are well known to perform multiple protein-protein interactions with master host cell factors, with the purpose to subvert important cellular functions, mostly oriented to promote cell survival and replication. These oncoproteins are obviously dispensable for normal cellular functions but can elicit 'oncogene addiction' in the infected/transformed cells. Both these issues suggest them as appealing targets for drug interference by small molecules able to modulate crucial interactions between these oncoproteins and specific cellular factors (47) .
In this view, the experimental data herein presented, together with the 3D molecular models proposed for the interaction between HPV-16 E7 and both GSN and N-termGSN, might straightforwardly be translated to therapy. In fact, molecularly targeted therapy could take advantage from these results in designing smart drugs capable of specifically dismantling the HPV-16 E7/GSN interaction. The derangement of this interaction could simultaneously impair either cancer cell survival and proliferation or cell motility. In fact, on one hand, thanks to the lack of a specific molecular target in non-infected non-transformed cells, these interfering molecules could hinder cell survival and replication in cancer cells only. On the other hand, they could affect the motile cytoskeletal machinery, thus modulating cell spreading, i.e. tumor invasiveness and aggressiveness. In few words, the targeting HPV-16 E7/GSN interaction could represent a novel rationale for the development of new therapeutic strategies aimed at the control of HPV-related neoplastic disease.
